Integrated Ayurvedic Management and Yoga Intervention in Non-alcoholic Fatty Liver Disease with Obesity: A Case Report
Keywords:
Arogyavardhini Vati, Non-alcoholic Fatty Liver, Phalatrikadi Kwatha, Yakrit Vikara, YogaAbstract
The buildup of excess fat within the liver cells in the absence of excessive alcohol consumption is known as nonalcoholic fatty liver disease (NAFLD). According to the WHO, the prevalence of chronic liver disease, such as NAFLD, has steadily increased in recent years. Ayurveda also provides a good description of liver disease. Pittasthana, Raktavahasrotomoola, Kaphamedo Dushti and Sthanasamsrava in Yakrut (liver) can all cause NAFLD, which is a Santarpanotha Vikara (illness). A 29-year-old patient presented to the out-patient department of Department of Swasthavritta, Ch. Brahm Prakash Ayurved Charak Sansthan, New Delhi with complaints of alteration in bowel habit, pain in epigastric region, gaseous abdomen from past 7–8 months. This case was diagnosed as Non-alcoholic Adipose Liver complaint on the base of ultrasonography report. The case was treated with Ayurvedic oral medicines, such as Arogyavardhini vati and Phalatrikadi kwatha by adding frequent yoga practices and got satisfactory results.
References
1. Acharya YT. Sushruta samhita. Vranaprasna. Sutrasthanam 21/10. 3rd ed. Varanasi: Chowkamba Krishnadas Academy Publications; 2014. p. 101.
2. Ralston SH, Penman ID, Strachan MW, Hobson R, editors. Liver and biliary disorders. In: Davidson’s principles and practice of medicine. 22nd ed., Ch. 13. London: Elsevier Health Sciences; 2018. p. 502.
3. Zhang X, Wu M, Liu Z, Yuan H, Wu X, Shi T, Chen X, Zhang T. Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: A population-based observational study. BMJ Open. 2021;11(5):e042843. doi: 10.1136/ bmjopen-2020-042843
4. Panda AK, Kar A, Gupta N, Yadav R, Mishra GS, Rout S. A consensus driven statement for Ayurvedic nomenclature of various liver diseases (Yakrit Roga). Int J Ayu Trad Med. 2021;3(5):16-21.
5. Kumar G, Srivastava A, Sharma SK, Gupta YK. Safety evaluation of an Ayurvedic medicine, Arogyavardhini vati on brain, liver and kidney in rats. J Ethnopharmacol. 2012;140:151-60.
6. Khandekar S, Pansare T, Pachpor A, Maurya SK. Role of katuka (Picrorhiza kurroa Royle ex Benth.) in obesity W.S.R to Ayurvedic and modern aspect: A review. Int J Herb Med. 2019;7:31-5.
7. Kumar S. The role of Ayurvedic management in non-alcoholic fatty liver disease (NAFLD): A case study. Int J Complement Alt Med. 2024;17(2):103-5. doi: 10.15406/ijcam.2024.17.00689
8. Kumar N, Singh AK. Phalatrikadi kvatha-an ayurvedic hepatoprotective drug. Int J Res Pharm Chem. 2013;3(3):591-4.
9. Shastri VS. Yogratnakar. Hindi commentry -vidyotini, pandu roga. 8th ed., 5th Sloka. Varanasi: Chaukhambha Sanskrit Sansthan; 2004. p. 3.
10. Srivastava S. Sharangdhar samhita, -jeevan prada. Madhyam khand. Ch. 2/77. Varanasi: Chaukhambha Orintalia; 2015. p. 147.
11. Manjunatha S, Vempati RP, Ghosh D, Bijlani RL. An investigation into the acute and long-term effects of selected yogic postures on fasting and postprandial glycemia and insulinemia in healthy young subjects. Indian J Physiol Pharmacol. 2005;49(3):319-24.
